The bacterial twin-arginine translocation (Tat) pathway facilitates the transport of correctly folded proteins across the tightly sealed cytoplasmic membrane. Here, we report the isolation and characterization of suppressor mutations in the Tat translocase that allow export of misfolded proteins, which form structures that are not normally tolerated by the wild-type translocase. Selection of suppressors was enabled by a genetic assay that effectively linked in vivo folding and stability of a test protein with Tat export efficiency of a selectable marker protein, namely TEM-1 β-lactamase. By using a test protein named α 3 B-a designed three-helix-bundle protein that forms collapsed, stable molten globules but lacks a uniquely folded structure-translocase mutants that rescued export of this protein were readily identified. Each mutant translocase still efficiently exported folded substrate proteins, indicating that the substrate specificity of suppressors was relaxed but not strictly altered. A subset of the suppressors could also export other misfolded proteins, such as the aggregation-prone α 3 A protein and reduced alkaline phosphatase. Importantly, the isolation of genetic suppressors that inactivate the Tat quality-control mechanism provides direct evidence for the participation of the Tat translocase in structural proofreading of substrate proteins and reveals epitopes in the translocase that are important for this process.
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protein folding | protein translocation | secretory pathway | membrane protein | library screening A hallmark of the twin-arginine translocation (Tat) pathway is its remarkable ability to transport folded proteins across tightly sealed, energy-transducing membranes, notably the bacterial cytoplasmic membrane and the chloroplast thylakoid membrane (for recent reviews, see refs. 1 and 2). This feat is accomplished by a translocase composed of the integral membrane proteins TatA, TatB, and TatC in bacteria or Tha4, Hcf106, and cpTatC, respectively, in chloroplasts. To remain competent for export, Tat substrates must fold properly in the cytoplasm before membrane translocation (3) (4) (5) (6) , with rare exceptions occurring in plant thylakoids (7, 8) or in bacteria where the levels of the TatABC proteins are artificially increased by 50-fold (9) . In one striking example, Escherichia coli alkaline phosphatase (PhoA) modified with a functional Tat signal peptide was only exported when its native disulfide bonds had been formed to generate the correctly folded molecule (3) . Based on these results, we hypothesized that a folding quality-control (QC) mechanism that discriminates between folded and mis/unfolded substrate proteins, allowing export of only the former, may be an inherent property of the Tat translocase (3) . In support of this hypothesis, even misfolded versions of Tat-targeted PhoA were observed to reach the Tat translocase, but these failed to be translocated (10, 11) . Further support of this hypothesis comes from the finding that the molecular contacts between misfolded PhoA and the TatBC components of the translocase differed from those of its correctly folded counterpart (10) .
On the basis of the above observations, it appears that the Tat translocase itself is at the center of an integrated QC system that involves "sensing" of the substrate folding state before transport and initiating degradation of those that are misfolded or misassembled. Such direct participation of the Tat translocase in substrate proofreading and degradation would provide a more rigorous QC system for some substrates, offering additional safeguards not afforded by accessory proteins. However, little is currently known about how this QC mechanism prevents the export of un/misfolded proteins. To investigate this phenomenon further, we previously developed a simple genetic selection for in vivo protein folding and stability that involved targeting proteins of interest to the Tat pathway (5). This selection was based on a tripartite fusion comprising a test protein that was inserted between the N-terminal Tat export signal of E. coli trimethylamine N-oxide reductase (ssTorA) and a C-terminal antibiotic resistance protein, TEM-1 β-lactamase (Bla). Properly folded test proteins fused to Bla were colocalized in the periplasm, thereby conferring resistance to β-lactam antibiotics (5). In contrast, unstable proteins were not exported to the periplasm, resulting in reduced cell resistance to antibiotics (5) . Hence, by using host cell resistance as a robust and generic readout, we showed that Tat export efficiency was directly linked to in vivo stability of the test protein. However, because most of the exportincompetent test proteins were marginally stable in vivo, they were likely eliminated by cellular QC mechanisms (e.g., degradation by proteases) that were independent of the Tat translocase.
Here, we extended the tripartite fusion system described above in a manner that more directly linked the Tat folding QC mechanism with antibiotic resistance. This feat was accomplished by using the α 3 family of designed three-helix-bundle proteins that represent a continuum of folded structures, ranging from aggregation-prone (α 3 A) and monomeric molten globules (α 3 B) to well-ordered three-helical bundles (α 3 C and α 3 D) (12, 13) . Using this selection, we isolated a set of suppressor mutants that rescued the export of the poorly folded α 3 B substrate; some of these could also export other misfolded proteins including α 3 A and PhoA. Although mutant translocases possessing relaxed signal peptide specificities have been reported (14, 15) , this work reports distinct mutant translocases that are less stringent with respect to the structural integrity of their substrates.
Results

Family of de novo Designed Proteins Links Tat Pathway QC to Antibiotic
Resistance. To develop a genetic assay that would allow direct selection of suppressors of Tat QC activity, we chose as the test protein the stable three-helix-bundle protein α 3 D, which was previously designed de novo by using a combination of structural motif design and computational sequence calculations (13) . This small, monomeric, 73-residue protein is ideal for our selection scheme because it lacks disulfides and shows thermodynamic and spectroscopic properties typical of well-folded native proteins. Moreover, there exist three progenitors of α 3 D that have welldefined structural and biophysical properties characteristic of nonnative (α 3 A and α 3 B) and native-like (α 3 C) proteins (12) . Of these, α 3 A is aggregation-prone and exists in a monomer/dimer/ trimer equilibrium as measured by sedimentation equilibrium, whereas α 3 B is completely monomeric but does not form a welldetermined structure and exhibits characteristics of the "molten globule" state. The α 3 C protein is not only monomeric but also native-like as assessed from its cooperative thermal unfolding, hydrogen-deuterium exchange, and the chemical shift dispersion of its NMR spectra. Importantly, despite their stability differences in vitro, the α 3 proteins were each expressed at similarly high levels in the yeast secretory pathway (16) . Based on this observation, we hypothesized that each of these proteins would have an equal chance of engaging the Tat translocase and undergoing structural proofreading in a manner that was not confounded or bypassed by competing cellular QC mechanisms.
To test this hypothesis, we generated four constructs whereby ssTorA was fused to each α3 protein. When each construct was expressed in the wild-type (wt) strain, α3C and α3D, but not α3A and α3B, were exported (Fig. 1A) . The export of α3C and α3D was strictly Tat-dependent, as confirmed by the retention of these substrates in the cytoplasm of B1LK0 cells (Fig. 1A) , which lack the tatC gene and are blocked for Tat export (17) . Consistent with our hypothesis, the α3 proteins exhibited comparable in vivo stability, as evidenced by the cytoplasmic accumulation of each in wt and ΔtatC cells. Next, the antibiotic resistance of strains expressing ssTorA-α 3 protein-Bla chimeras was measured by spotting dilutions of cells onto solid medium containing ampicillin (Amp). Fig.   1B shows one such experiment: Using agar plates supplemented with 200 μg/mL Amp, we compared the growth conferred by the α 3 proteins. In line with their in vitro stability, the Amp resistance conferred to wt cells by each clone was in the following order (from highest to lowest): α 3 D > α 3 C >> α 3 B > α 3 A (Fig. 1B and  Fig. S1 ). Hence, these α 3 constructs provide a simple yet robust readout of Tat QC activity by linking substrate stability with antibiotic resistance. When each of these clones was expressed in ΔtatC cells, the Amp resistance phenotypes were markedly diminished (Fig. 1B) , confirming that export was Tat dependent. In all cases, the resistance of cells grown on plates lacking Amp was nearly identical, indicating that the different Amp-resistant phenotypes were specific to Tat-mediated export of the α 3 proteins and not reduction in fitness caused by their expression.
In agreement with the Amp resistance data, α 3 C-Bla and α 3 D-Bla were localized exclusively in the periplasm, whereas α 3 A-Bla and α 3 B-Bla accumulated entirely in the cytoplasm (Fig. 1C) . The faster migration observed for α 3 C-Bla and α 3 DBla was indicative of ssTorA removal during membrane translocation, whereas the lack of signal peptide processing for α 3 ABla and α 3 B-Bla was consistent with their retention in the cytoplasm. Furthermore, the same constructs were undetectable when expressed in ΔtatC cells (Fig. 1C ). This result, although somewhat different from the situation in which the α3 proteins were expressed without the Bla domain, is consistent with previous observations that nonexported substrates (i.e., in tat-deficient strains) become rapidly degraded (3, 5) . Together, these data corroborate the notion that proteins of varying order and stability are differentially exported via the Tat pathway.
Isolation of Mutant TatABC Translocases That Suppress Folding QC.
The fact that α 3 A and α 3 B were stably expressed and yet blocked for export suggests that these substrates may engage the Tat translocase and, further, that the translocase itself may be involved in structural proofreading. If this interpretation is correct, then genetic suppressors could be isolated that inactivate TatABC-mediated QC and permit export of the otherwise export-defective α 3 A and α 3 B proteins. To this end, we first evaluated coexpression of plasmid-encoded copies of tatABC in the tat deletion strain DADE (ΔtatABCDΔtatE) (18) carrying the different ssTorA-α 3 constructs. Similar to the case in wt cells above, DADE cells complemented with wt tatABC genes in plasmid pBR322 exported α3C and α3D, but not α3A and α3B ( Fig. 2A) . Likewise, when the α 3 -Bla chimeras were expressed in these cells, the Amp-resistance phenotypes and the subcellular distribution of the α 3 -Bla fusions were nearly identical to the case with genomic copies of wt tatABC ( Fig. 2 B and C) . Next, a plasmid library of tatABC genes was cotransformed into DADE cells carrying ssTorA-α 3 B-Bla. We chose α 3 B because it was blocked for export but still accumulated in the cytoplasm (i.e., it was available to be exported) and also because it is not prone to aggregation (12) . DADE/pSALect-α 3 B cells expressing the mutated tatABC alleles were selected on Amp concentrations that previously inhibited growth. Ten mutant translocases (designated "QCS" for QC suppressor) that reproducibly conferred the highest Amp resistance were obtained and studied further.
DNA sequencing of the entire tatABC region revealed that all QCS clones except Mut64 contained amino acid substitutions in all three translocase components; Mut64 carried substitutions in TatB and TatC, but not TatA (Table S1 and Fig. S2 ). All of the QCS mutants were unique with only a few identical or similar mutations shared by the clones, and these were all in the TatC component: F94I/L/Y, P97S, A98T, and N247D/S. Importantly, all 10 clones conferred a level of resistance to DADE/ pSALect-α 3 B cells that was identical to the resistance observed for DADE/pSALect-α 3 D cells in the presence of wt tatABC expressed from pBR322 (Fig. 2B) . The newly acquired ability to export misfolded α 3 B did not disrupt the ability of the QCS mutants to export well-folded proteins because all 10 conferred equally high resistance to DADE/pSALect-α 3 C and -α 3 D cells. Moreover, three of these clones (mut51, mut57, and mut66) conferred similarly high resistance to DADE/pSALect-α 3 A cells, whereas the other clones did not (Fig. 2B ). Based on this distinction, clones mut51, mut57, and mut66 were designated as class I suppressors, whereas the others were designated as class II. In agreement with the Amp resistance data, both class I and II suppressors were capable of exporting ssTorA-α 3 B-Bla, ssTorA-α 3 C-Bla, and ssTorA-α 3 D-Bla, whereas only the class I suppressors exported ssTorA-α 3 A-Bla (Fig. 2C) . Hereafter, we focused our attention on the class I suppressors. To determine whether class I suppression was related to intracellular abundance of translocase proteins, the expression level of the mutant Tat proteins was analyzed by immunoblotting (14, 15) . Nearly equal amounts of TatA were detected in membranes from cells expressing wt and mutant Tat translocases, whereas subtle differences in TatB expression were observed (Fig.  S3) . Initial attempts to detect TatC were unsuccessful, likely because of the low expression level from pBR322, as was reported (15) . To circumvent this problem, a small epitope tag was fused to the C terminus of TatC, which is known to tolerate C-terminal fusions without loss of function (15) . Importantly, the wt and suppressor copies of epitope-tagged TatC were all expressed at similar levels in membranes (Fig. S3) . Thus, at least for class I mutants, the degree of suppression is not attributable to gross differences in TatABC expression; although, we cannot rule out that suppression somehow arises from subtle expression differences.
QCS Mutants Translocate Native Substrates. We next investigated whether class I QCS mutants had completely changed their substrate specificity or could still accept native Tat substrates. In E. coli, the N-acetylmuramoyl-L-alanine amidases AmiA and AmiC cleave the peptide moiety of the N-acetylmuramic acid in peptidoglycan and are both Tat substrates (19) . Mutations that impair Tat export and prevent periplasmic localization of AmiA and AmiC render E. coli sensitive to SDS and disrupt cell division (19) . The cell division defect results in the formation of cell chains ranging from 6 to 24 cells in length. DADE cells expressing wt or suppressor translocases showed no visible cell-division defects, whereas DADE control cells formed characteristic chains (more than six cells per chain) (Fig. 3A) . Similar results were observed with class II translocases. There were also no obvious growth defects in liquid culture (Fig. 3B) . Efficient export of two other Tat substrates, CueO and SufI, that were each modified with a Cterminal FLAG epitope tag (20) , was observed when each was coexpressed with the class I suppressors in DADE (Fig. 3C) . Together, these results confirm that suppressors retain the ability to export native substrates. Moreover, given that the steady-state level of export by each class I QCS translocase was nearly the same as the wt translocase, the suppressor phenotype cannot be ascribed to hyperactivity of the QCS mutants.
To rule out the possibility of multicopy artifacts, we used CRIM (conditional-replication, integration, and modular) plasmid technology (21) to stably integrate wt or QCS translocase genes in single copy into the chromosome of DADE cells. Importantly, when expressed at physiological levels in DADE integrants, wt and class I suppressor mutants promoted nearly identical Amp-resistant phenotypes as their plasmid-encoded counterparts (Fig. S4A) , albeit at expectedly lower Amp concentrations than in the multicopy case due to lower expression of the translocase genes. All DADE integrants were also observed to reverse the chain phenotype normally associated with cells that lack tatABC (Fig. S4B) . The ability of QCS translocases expressed at physiological levels to export natively produced AmiA and AmiC provides additional strong evidence that the suppressors still retained normal translocation function.
Class I QCS Mutants Export Folded and Misfolded Substrate Proteins.
To further explore substrate specificity, we evaluated the ability of the class I QCS mutants to export folded green fluorescent protein (GFP) or misfolded PhoA. When GFP is targeted to the Tat pathway, it accumulates in the periplasm in an active state (22) . Because GFP is incapable of folding in the periplasm when targeted via the Sec pathway (23), Tat-targeted GFP must fold completely in the cytoplasm and be exported in a fully folded, active conformation. Imaging studies revealed a halo of fluorescence in cells expressing class I suppressors with significant GFP accumulation at the cell poles (Fig. 3D) , a subcellular pattern consistent with Tat export of folded GFP in wt strains (22) . Western blot analysis confirmed that GFP was localized in the periplasm of these cells (Fig. 3C) . Hence, class I suppressors still exported folded substrates.
In the case of PhoA, we previously demonstrated that this protein was only exported by the Tat pathway if its native disulfide bonds had formed to generate the correctly folded molecule in the cytoplasm before export (3). Here, we hypothesized that PhoA expression in the reducing cytoplasm of wt E. coli cells would result in a misfolded substrate that could be exported by the class I suppressors. To test this hypothesis, we monitored in vivo export of ssTorA-PhoA (3) using Luria Bertani (LB)-agar plates supplemented with 5-bromo-4-chloro-3-indolyl phosphate (BCIP), a colorimetric substrate that emits a visible blue color when hydrolyzed by PhoA. Because BCIP diffusion through the inner membrane of E. coli is very inefficient, it is an excellent indicator of PhoA activity in the E. coli periplasm (24) . Remarkably, cells expressing class I suppressor translocases appeared to export reduced ssTorA-PhoA as evidenced by a strong blue phenotype, whereas cells expressing wt translocases were colorless, indicating that reduced ssTorAPhoA was not exported (Fig. 4A) . Western blot analysis confirmed that PhoA was exported from the reducing cytoplasm of cells expressing class I suppressors, but not wt translocases (Fig.  4B ). In addition, only class I suppressors accumulated appreciable amounts of ssTorA-PhoA precursor in the cytoplasm, suggesting that the nonexported PhoA in cells expressing the wt translocase was rapidly degraded. Interestingly, class II suppressors, which could only export ssTorA-α 3 B-Bla, but not ssTorA-α 3 ABla, were incapable of exporting misfolded PhoA (Fig. 4A) .
QCS Mutants Retain Strict Signal Peptide Specificity. As mentioned above, suppressor translocases that allow export of defective signal peptides have been reported (14, 15) . Interestingly, three of the signal peptide suppressors carried mutations in TatC that were identical (P97S) or similar (L9F, F94S) to QCS mutations (Table S1 ). In light of these shared mutations, we next determined whether QCS translocases could export substrates bearing defective Tat signals in which the twin-arginine residues were swapped to twin lysines. For this analysis, we chose to use the fluorescent reporter ssTorA-GFP-SsrA (TGS), which allows quantitative detection of Tat export by flow cytometry (25) and was used to isolate signal peptide suppressor translocases (15) . The presence of the SsrA tag on GFP ensured that any fusion protein that failed to be exported via the Tat pathway was degraded by ClpXP. Thus, cell fluorescence arises only from TGS that has been sequestered away from the proteolytic machinery following Tat-dependent export into the periplasm. DADE cells coexpressing TGS along with wt copies of tatABC were highly fluorescent (Fig. S5) . In contrast, mutation of the conserved Arg-Arg dipeptide within the signal peptide of TGS to Lys-Lys [ssTorA(KK)-GFP-SsrA or KGS] effectively blocked Tat export and reduced fluorescence to the background level (Fig. S5) . This reduction represented a sevenfold decrease compared with the positive TGS control. As expected, KGS was exported by cells expressing signal peptide suppressors such as the F94S and W92G/P97S tatC mutants isolated by Strauch and Georgiou (15) , as evidenced by a twofold to threefold increase in fluorescence compared with cells carrying the wt translocase (Fig. S5) . In contrast, the fluorescence of DADE/KGS cells expressing QCS translocases was indistinguishable from cells expressing the wt translocase (Fig. S5) . These results indicate that QCS mutants retain strict specificity for the wt ssTorA signal peptide and do not operate at the level of signal peptide recognition. Creation of Hybrid Translocases That Still Suppress QC. To narrow the number of mutations needed for suppression, we created hybrid mutant/wt translocases by systematically replacing one or two of the mutated tat alleles from each class I QCS mutant with the corresponding wt allele(s). For example, combining the mutant tatC allele from mut51 along with wt tatAB alleles gave rise to a new translocase variant harboring only the tatC mutations P97S and A133T. This hybrid translocase recapitulated the class I suppressor phenotype (Fig. S6A) . Further decomposition of this tatC allele revealed that neither P97S nor A133T alone was capable of class I suppression (Fig. S6B) . Interestingly, the A133T mutation abolished function, whereas the P97S mutant gave a class II-like phenotype (Fig. S6B) . Like all QCS mutants, P97S did not export KGS (Fig. S5) , whereas W92G/P97S substitution in tatC yielded a signal peptide suppressor that exported KGS (Fig. S5) (15) . For mut57, the tatA and tatC mutant alleles gave rise to class II suppression when each was combined with wt counterparts. Achieving class I suppression, however, required combination of the mutant tatB and tatC alleles. For mut66, the mutant tatA allele, which encodes two glycine-to-serine substitutions at residues 2 and 3, was solely capable of class I suppression. It is noteworthy that the mut51 and mut66 tatB mutant alleles each resulted in nonfunctional translocases when combined with wt copies of tatAC; however, when paired with the mutant tatC or tatA allele, respectively, functional class I suppressor translocases were formed. A similar phenomenon was observed for the class II suppressor mut73: The tatB and tatC alleles, which each carried just a single amino acid substitution (A98S and F94L, respectively), individually resulted in a loss-offunction phenotype; however, their interaction had a synergistic effect, resulting in the gain-of-function suppressor phenotype (Fig. S6A) . It is noteworthy that the F94S and W92G/P97S signal peptide suppressors (15) , which shared the same or similar substitutions as our mut51 and mut73 mutants, did not rescue export of α 3 A and α 3 B (Fig. S6B) . In fact, the F94S and W92G/ P97S mutants were completely inactive in our system, as evidenced by their inability to export even the well-behaved α 3 C and α 3 D constructs. This result was not entirely surprising, given that these signal peptide suppressors resulted in defective translocases that exhibited an ∼80% reduction in the export of TGS and reduced ability to export authentic Tat substrates as manifested by septation defects and SDS sensitivity (15) . Hence, despite the occurrence of a few shared mutations, there was no overlapping suppressor activity between QCS and signal peptide suppressor translocases. Together, our suppressors represent a distinct class of translocase mutants that are uniquely capable of overriding folding QC.
Discussion
Here, we identified several genetic suppressors that export a misfolded protein, α 3 B, whose structure was not tolerated by the wt translocase. Given that all QCS translocases still efficiently exported native and nonnative substrates that were correctly folded, we conclude that the substrate specificity of the suppressors was not entirely changed; rather, the translocases acquired an increased tolerance toward structural variations in certain substrates. Moreover, the class I, but not class II, suppressors appeared to have an even broader substrate specificity with respect to misfolded proteins, because they also gained the ability to export the aggregation-prone α 3 A protein as well as reduced PhoA. In light of this difference in functional complexity, it is interesting to note that class II suppression could be achieved with just a single substitution in tatA (e.g., mut57) or tatC (e.g., P97S), whereas the more complex class I suppressor phenotype required two or more amino acid substitutions in either tatA (e.g., mut66) or tatC (e.g., mut51).
Productive interactions between the substrate protein and translocase components are emerging as key features of the Tat QC mechanism (10, 11) . However, there is currently very little known about the nature of these interactions or the domain(s) in the translocase that might be involved. Our QCS mutants shed light on this issue by revealing a strong mutational bias in specific regions of TatBC, which is consistent with the notion that these components form a substrate receptor complex (14, 15, 26, 27) . Along these lines, mut73 achieved class II suppression with substitutions in just one residue each in TatB (A98S) and TatC (F94L). More generally, suppressor mutations were clustered in the membrane-extrinsic domain of TatB (residues 90-140) and the first cytoplasmic loop of TatC between predicted transmembrane helices II and III (residues 94-105). The functional significance of this latter region in QC activity is reflected in the fact that 7 of the 10 best QCS mutants contained one or two mutations in this region of TatC. Of these, more than half were in residues F94, P97, or E103, and one, P97, was capable of conferring class II suppression when substituted with serine. These findings are all the more remarkable given that individual substitutions in these residues have been reported by others to severely reduce (e.g., P97) or completely block (e.g., F94L, F94Y, and E103D) translocation activity (28) , whereas in our studies these sites were isolated as gain-of-function mutations when combined with one or more additional mutations in TatA, TatB, and/or TatC.
The ability to select suppressor alleles that export misfolded proteins suggests that the transport and QC functions of the translocase can be separated. Isolation of these alleles supports our proposal that there is a specific QC domain within the translocase that is physically distinct from the transport apparatus. It argues against the opposing view that unsuccessful transport is due to inherent incompatibility with the physical mechanism of Tat protein transport, because in this model transport and QC have a single mechanistic origin. However, because some of the substitutions are of residues previously implicated in transport or signal peptide specificity, our argument for separate transport and QC functions cannot be regarded as the definitive interpretation of the suppressor alleles until the mechanistic basis of the QCS phenotype is established. How might the Tat translocase discriminate between folded and misfolded substrates? At present, the details of this activity remain unclear. Because an exposed hydrophobic core is the typical hallmark of misfolded and aggregation-prone proteins, one possible explanation for how the Tat system might monitor the folding state of its substrates is via hydrophobic interactions between specific regions of the TatBC components and the substrate itself. Richter et al. (9) recently reported that surfaceexposed hydrophobic patches blocked Tat export and suggested that translocation might become stalled when those hydrophobic side chains contact membrane lipids. Based on our findings, an alternative explanation is that hydrophobic surface patches on nonnative proteins might be recognized by TatBC. The cytoplasmic domain of TatB, which is predicted to form a coiled coil and also helps promote dimerization between membrane-extrinsic domains of TatB (29) , could serve as part of this folding sensor. Upon sensing misfolded proteins, TatB could then hand the substrates off to ancillary proofreading factors, such as molecular chaperones that complete the folding reaction or proteases that dispose of rejected molecules. Importantly, misfolded substrates that are bound by the translocase folding sensor may induce a structural alteration in TatB that precludes the next step in the translocation cycle, namely the ΔpH-dependent recruitment of TatA to the receptor complex (30) . Indeed, the molecular contacts between a misfolded substrate and both the TatB and TatC proteins differ from those of a folded, translocation-competent substrate (10) . Regardless of the mechanism, the genetic suppressors isolated here should help contribute to our understanding of the QC mechanism that regulates Tat export, much in the same way that the prl suppressors (31) helped dissect the Sec protein export mechanism.
Materials and Methods
For additional materials and methods, see SI Materials and Methods.
Bacterial Strains and Plasmids. All strains and plasmids used in this study are described in SI Materials and Methods and listed in Table S2 .
Selective Plating of Bacteria. Bacterial plating was performed as described (5, 32) . Briefly, DADE cells harboring pTatABC and one of the pSALect-α 3 plasmids were grown overnight at 37°C in LB medium supplemented with 10 μg/mL tetracycline (Tet) and 25 μg/mL chloramphenicol (Cam). The next day, 100 μL of cells was medium-exchanged with fresh LB (no antibiotics), and subsequently serially diluted by factors of 10 in 96-well plates. Aliquots of 5 μL from each well were spotted onto LB-agar plates containing Cam (control) or Amp, and plates were incubated at 30°C for ∼16.5 h. Subcellular Fractionation and Western Blot Analysis. Overnight cells were subcultured 10-fold in LB containing antibiotics and allowed to grow for 1.5 h at 37°C until a cell density (A 600 ) of ∼0.5 was reached, at which time the cultures were induced with 1 mM IPTG or 0.2% arabinose and incubated at 30°C. Protein expression proceeded at 30°C for ∼16.5 h for pSALect-based substrates or ∼2-4 h for all other substrates, after which cultures were pelleted via centrifugation for 15 min at 4°C and 2,500 × g. Cell pellets were subsequently fractionated according to the ice-cold osmotic shock method, as described (3) . Membrane fractions were prepared as described (14) . Proteins were separated by SDS/PAGE using 12% (wt/vol) polyacrylamide gels (Bio-Rad) or, for detection of α 3 proteins without the Bla domain, on TGX Any kDa gels (Bio-Rad) and subsequently detected by Western blotting according to standard protocols by using the following primary antibodies: mouse anti-Bla (Abcam), rabbit anti-GroEL (Abcam), mouse anti-FLAG M2-HRP (Sigma-Aldrich), rabbit anti-GFP-HRP (Abcam), rabbit anti-PhoA-HRP (Abcam), and anti-TatA, anti-TatB, and anti-TatC serum (14) .
